enVVeno Medical Corporation $NVNO Shares Sold by Westside Investment Management Inc.

Westside Investment Management Inc. decreased its holdings in shares of enVVeno Medical Corporation (NASDAQ:NVNO) by 56.5% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 92,650 shares of the company’s stock after selling 120,150 shares during the period. Westside Investment Management Inc. owned approximately 14.04% of enVVeno Medical worth $30,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Kingdon Capital Management L.L.C. grew its position in enVVeno Medical by 58.2% during the 3rd quarter. Kingdon Capital Management L.L.C. now owns 1,359,261 shares of the company’s stock worth $1,232,000 after purchasing an additional 500,000 shares during the last quarter. CM Management LLC acquired a new stake in enVVeno Medical during the 3rd quarter worth about $544,000. Perceptive Advisors LLC acquired a new position in shares of enVVeno Medical in the second quarter valued at about $5,127,000. Jane Street Group LLC acquired a new stake in shares of enVVeno Medical during the second quarter worth about $51,000. Finally, Creative Planning purchased a new stake in enVVeno Medical in the second quarter valued at approximately $54,000. 34.71% of the stock is owned by hedge funds and other institutional investors.

enVVeno Medical Stock Down 1.5%

enVVeno Medical stock opened at $10.88 on Tuesday. The firm has a market cap of $7.14 million, a price-to-earnings ratio of -0.29 and a beta of 1.09. The business’s 50-day moving average price is $10.60 and its 200 day moving average price is $15.24. enVVeno Medical Corporation has a 52 week low of $8.67 and a 52 week high of $196.70.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of enVVeno Medical in a report on Friday, March 27th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

enVVeno Medical Profile

enVVeno Medical, Inc is a clinical‐stage medical device company focused on the development and commercialization of subcutaneous vascular access systems for patients requiring repeated or long‐term intravenous therapy. Through its proprietary Freedom® platform, the company aims to offer an implantable alternative to traditional peripherally inserted central catheters (PICCs) and external tunneled catheters, addressing complications such as infection risk, dislodgement and patient discomfort.

The company’s lead product candidate, the Freedom PICC System, consists of a low‐profile, subcutaneous port connected to a flexible catheter designed for peripheral insertion.